The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2-Methoxy-5-(3,4,5-trimethoxy-phenylamino)-phenol ID: ALA150463
PubChem CID: 10380369
Max Phase: Preclinical
Molecular Formula: C16H19NO5
Molecular Weight: 305.33
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: COc1ccc(Nc2cc(OC)c(OC)c(OC)c2)cc1O
Standard InChI: InChI=1S/C16H19NO5/c1-19-13-6-5-10(7-12(13)18)17-11-8-14(20-2)16(22-4)15(9-11)21-3/h5-9,17-18H,1-4H3
Standard InChI Key: MJYKDEBIQGCYQN-UHFFFAOYSA-N
Molfile:
RDKit 2D
22 23 0 0 0 0 0 0 0 0999 V2000
1.8042 -3.0292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2042 -3.4792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.0000 -2.4542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9792 -2.7792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5875 -2.3292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.7917 -3.3542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9625 -3.4292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5542 -2.9875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5667 -2.6625 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.9750 -3.1167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7792 -4.0042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1917 -4.1292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2125 -3.1500 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.7875 -3.6875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.6042 -1.9917 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.0167 -4.0542 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.5542 -3.3042 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.1792 -4.4542 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
0.8125 -2.7000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4167 -4.5042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0125 -2.1042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0000 -5.0250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 1 1 0
4 5 1 0
5 3 2 0
6 2 1 0
7 8 2 0
8 10 1 0
9 4 1 0
10 9 1 0
11 12 2 0
12 14 1 0
13 1 1 0
14 10 2 0
15 3 1 0
16 2 1 0
17 7 1 0
18 11 1 0
19 13 1 0
20 16 1 0
21 15 1 0
22 18 1 0
4 6 2 0
11 7 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 305.33Molecular Weight (Monoisotopic): 305.1263AlogP: 3.17#Rotatable Bonds: 6Polar Surface Area: 69.18Molecular Species: NEUTRALHBA: 6HBD: 2#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 10.09CX Basic pKa: 1.74CX LogP: 2.48CX LogD: 2.48Aromatic Rings: 2Heavy Atoms: 22QED Weighted: 0.85Np Likeness Score: -0.15
References 1. Lawrence NJ, Rennison D, Woo M, McGown AT, Hadfield JA.. (2001) Antimitotic and cell growth inhibitory properties of combretastatin A-4-like ethers., 11 (1): [PMID:11140732 ] [10.1016/s0960-894x(00)00596-5 ] 2. Ducki S, Mackenzie G, Lawrence NJ, Snyder JP.. (2005) Quantitative structure-activity relationship (5D-QSAR) study of combretastatin-like analogues as inhibitors of tubulin assembly., 48 (2): [PMID:15658859 ] [10.1021/jm049444m ]